MedTrace Logo

Treatment of Chemotherapy and Radiotherapy Induced Oral Mucositis

NCT04303312 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 54

Last updated 2021-08-06

No results posted yet for this study

Summary

Oral mucositis consequences can range from pain, decreased oral intake, impaired speech and swallowing to adverse events as severe as septicemia, increased hospitalization, and G-tube feeding A wide variety of agents have been tested to prevent OM or reduce its severity.This trial will assess the usefulness of solcoseryl and pumpkin seed oil versus Benzydamine Hydrochloride mouth wash in management of oral mucositis in patients receiving radiotherapy and/or chemotherapy.

Conditions

  • Mucositis Oral

Interventions

OTHER

Benzydamine Hydrochloride

Patients will rinse by mouth three times daily for 20 days

COMBINATION_PRODUCT

Solcoseryl and pumpkin seed oil

Patients will receive by mouth three times daily for 20 days

Sponsors & Collaborators

  • Ghada zaki

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
89 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-12-31
Primary Completion
2021-12-30
Completion
2022-03-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04303312 on ClinicalTrials.gov